Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R antibody fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites-Reference-Cited by-同舟云学术

Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R antibody fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites

Published:2018-04 Issue: Volume:150 Page:46-53
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Li Caina,Yang Miaomiao,Wang Xiaofeng,Zhang Hua,Yao Chenjiang,Sun Sujuan,Liu Quan,Pan Hao,Liu Shuainan,Huan Yi,Li Shengnan,Cao Jun,Wang Xing,Guo Yong,Guo Nan,Jing Shuqian,Zhang Cheng,Shen Zhufang

Funder

CAMS Initiative for Innovative Medicine

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference23 articles.

1. β-cell dysfunction: its critical role in prevention and management of type 2 diabetes;Saisho;World J. Diab.,2015

2. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications;Frier;Nat. Rev. Endocrinol.,2014

3. Impact of weight gain on outcomes in type 2 diabetes;Ross;Curr. Med. Res. Opin.,2011

4. Glucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications;Manandhar;J. Med. Chem.,2015

5. Targeting incretins in type 2 diabetes: role of GLP-1 receptor agonists and DPP-4 inhibitors;Richard;Rev. Diabet. Stud.,2008

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-Mediated Ocular Surface Disease in Diabetes Mellitus—Clinical Perspectives and Treatment: A Narrative Review;Biomedicines;2024-06-12

2. Animal Models in Eye Research: Focus on Corneal Pathologies;International Journal of Molecular Sciences;2023-11-23

3. A Critical View over the Newest Antidiabetic Molecules in Light of Efficacy—A Systematic Review and Meta-Analysis;International Journal of Molecular Sciences;2023-06-05

4. Discovery and design of G protein-coupled receptor targeting antibodies;Expert Opinion on Drug Discovery;2023-03-29

5. Generation of novel long-acting GLP-1R agonists using DARPins as a scaffold;International Journal of Pharmaceutics;2021-09